Bioresorbable stent technology was one of the big interventional technologies discussed at the American College of ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
April 1, 2014 — The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat ...
![Terumo Corp. Arterial Remodeling Technologies Bioresorbable Coronary Stent](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Terumo_MISAGO%20STENT.jpeg?itok=c1Z9g5wK)
March 31, 2014 — Privately held Arterial Remodeling Technologies (ART) signed a structured buyout agreement with Terumo ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
![](/sites/default/files/styles/content_feed_large/public/field/image/stent_with_cover_.png?itok=TbMrMoPc)
March 26, 2014 — Inspire MD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using ...
March 18, 2014 — Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from ...
March 13, 2014 — Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the ...
March 12, 2014 — Micell Technologies Inc. announced that imaging and clinical results from the DESSOLVE I and DESSOLVE ...
March 3, 2014 — OrbusNeich announced that patient enrollment has initiated in Japan in the pivotal clinical trial of the ...
![Percuntaneous Coronary Intervention PCI Cath Lab Stents Clinical Trial Study](/sites/default/files/styles/content_feed_large/public/field/image/30jan%20-%20PCI%20Report.jpg?itok=mSrmRjSx)
January 23, 2014 – Six-month results of the ESPRIT trial suggest a bioresorbable drug-eluting scaffold is effective in ...
![Carotid Stent Clinical Study Abbott Cordis National Cardiovascular Data Registry](/sites/default/files/styles/content_feed_large/public/field/image/23jan%20-%20Study%20Finds%20No%20Significant%20Differences%20Between%20Commonly%20Used%20Carotid%20Stenting%20Systems.jpg?itok=_QCgMDXF)
![cath lab stents bioresorbable amaranth fortitude scaffold](/sites/default/files/styles/content_feed_large/public/field/image/Amaranth%20Medical%20Fortitude%20scaffold.jpg?itok=CNV97FjL)